Literature DB >> 1822247

Antisense DNA downregulates protein kinase C isozymes (beta and alpha) and insulin-stimulated 2-deoxyglucose uptake in rat adipocytes.

R V Farese1, M L Standaert, T Ishizuka, B Yu, H Hernandez, C Waldron, J Watson, J P Farese, D R Cooper, E Wickstrom.   

Abstract

Rat adipocytes were treated with antisense dimethoxytrityl pentadecadeoxynucleotides, complementary to mRNA initiation codon regions for alpha and beta isozymes of protein kinase C (PKC). This antisense treatment provoked 50-70% decreases in PKC and insulin-stimulated 2-deoxyglucose uptake, but did not inhibit insulin-stimulated diacylglycerol synthesis. Sense or nonsense oligodeoxynucleotides were without effect on PKC and 2-deoxyglucose uptake. These results suggest that: (i) PKC-alpha and PKC-beta isozymes can be specifically downregulated in rat adipocytes by antisense oligodeoxynucleotides, and (ii) insulin-stimulated glucose transport requires PKC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822247     DOI: 10.1089/ard.1991.1.35

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN: 1050-5261


  4 in total

Review 1.  Oligonucleotide treatment of ras-induced tumors in nude mice.

Authors:  E Wickstrom
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

Review 2.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

3.  The phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits insulin-induced activation of phosphatidylcholine hydrolysis and associated protein kinase C translocation in rat adipocytes.

Authors:  M L Standaert; A Avignon; K Yamada; G Bandyopadhyay; R V Farese
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

4.  Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular Disease.

Authors:  Raouf A Khalil
Journal:  Pharmaceuticals (Basel)       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.